Home › Calculator › BBNX Dividend Calculator 2026
BBNX Dividend DRIP Calculator 2026
12.35% YieldHealthcareBeta Bionics, Inc. · NASDAQ
Price: $16.20 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BBNX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BBNX snowball 📈
$10,000 in BBNX → $11.56M in 10 years · $116.09/month
About Beta Bionics, Inc. (BBNX) — Dividend Analysis 2026
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Compare BBNX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BBNX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BBNX position with:
🌍 BBNX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BBNX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 12.35% | 9.55% | $1,235 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 10.50% | 7.70% | $1,050 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.88% | 7.08% | $988 / yr |
| 🇬🇧 UK ISA | 0% | 12.35% | 9.55% | $1,235 / yr |
| 🇬🇧 UK Taxable | 8.75% | 11.27% | 8.47% | $1,127 / yr |
| 🇨🇦 TFSA | 0% | 12.35% | 9.55% | $1,235 / yr |
| 🇨🇦 CA Taxable | 25% | 9.26% | 6.46% | $926 / yr |
| 🇦🇺 Super (pension) | 15% | 10.50% | 7.70% | $1,050 / yr |
| 🇦🇺 AU Taxable | 30% | 8.64% | 5.84% | $865 / yr |
| 🇩🇪 DE Taxable | 26.375% | 9.09% | 6.29% | $909 / yr |
| 🇫🇷 FR Taxable | 30% | 8.64% | 5.84% | $865 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BBNX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BBNX Dividend Payment Schedule
BBNX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BBNX vs Healthcare Benchmarks
How BBNX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BBNX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BBNX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-06-26 | 5,104 | $5.10 | $26.0K | ||
| M-Exempt | 2026-06-29 | 4,896 | $5.10 | $25.0K | ||
| Sale | 2026-06-29 | 4,896 | $17.03 | $83.4K | ||
| Sale | 2026-06-26 | 5,104 | $17.05 | $87.0K | ||
| M-Exempt | 2026-06-26 | 5,104 | $5.10 | $26.0K | ||
| M-Exempt | 2026-06-29 | 4,896 | $5.10 | $25.0K | ||
| M-Exempt | 2026-06-26 | 4,982 | $5.10 | $25.4K | ||
| M-Exempt | 2026-06-29 | 4,896 | $5.10 | $25.0K | ||
| Sale | 2026-06-26 | 5,104 | $17.05 | $87.0K | ||
| Sale | 2026-06-29 | 4,896 | $17.03 | $83.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BBNX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Beta Bionics, Inc. (BBNX) is currently trading at $16.20, 45% below its 52-week high. The current dividend yield is 12.35% based on an annual payout of $2.00 per share.
BBNX (Beta Bionics, Inc.) — 12.35% Dividend Yield Analysis
Beta Bionics, Inc. (BBNX) is a healthcare stock currently trading at $16.20 with a dividend yield of 12.35%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (12.35%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.